APA (7th ed.) Citation

Philip Lammers, Carmen Criscitiello, Giuseppe Curigliano, & Ira Jacobs. (2014). Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets. MDPI AG.

Chicago Style (17th ed.) Citation

Philip Lammers, Carmen Criscitiello, Giuseppe Curigliano, and Ira Jacobs. Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets. MDPI AG, 2014.

MLA (9th ed.) Citation

Philip Lammers, et al. Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets. MDPI AG, 2014.